The first Turning Point Therapeutics trade was made in Q2 2019.
Since then Ken Griffin bought shares seven more times and sold shares on four occasions. The investor completely sold their stake between Q2 2022 and Q3 2022.
Avg closing price
Price range
Sold -166 Thousand shares
Q3 2022
Avg closing price
$75.07
Price range
$74.65
-
$76.01
Sold 80.0% shares (-661 Thousand shares)
Q2 2022
Avg closing price
$44.44
Price range
$24.32
-
$75.30
Increased shares by 27.9% (+181 Thousand shares)
Q1 2022
Avg closing price
$33.60
Price range
$24.73
-
$51.25
Increased shares by 167.1% (+404 Thousand shares)
Q4 2021
Avg closing price
$44.71
Price range
$35.48
-
$67.33
Increased shares by 3311.6% (+235 Thousand shares)
Q3 2021
Avg closing price
$71.24
Price range
$61.00
-
$81.99
Sold 93.2% shares (-96.9 Thousand shares)
Q2 2021
Avg closing price
$73.90
Price range
$62.93
-
$90.59
Increased shares by 1.2% (+1.26 Thousand shares)
Q1 2021
Avg closing price
$118.91
Price range
$88.19
-
$140.01
Increased shares by 100.5% (+51.5 Thousand shares)
Q3 2020
Avg closing price
$69.66
Price range
$56.99
-
$89.33
Increased shares by 330.1% (+39.3 Thousand shares)
Q2 2020